Clinical Trial

Wireless Assessment of Respiratory and Circulatory Distress - Europe

Study acronym: WARD-EU
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Hospital patient monitoring in Europe is often intermittent, which can delay detection of clinical deterioration during hospitalization and after discharge. The WARD-EU study aims to describe current monitoring practices and to evaluate the feasibility, acceptability, and usability of the WARD-CSS (Wireless Assessment of Respiratory and Circulatory Distress - Clinical Support System), an algorithm-based continuous monitoring system. The study seeks to assess whether WARD-CSS can be integrated into routine hospital and post-discharge care to support earlier detection of patient deterioration and improved patient monitoring.
Trial Details
NCT Number NCT07451249
Lead Sponsor Eske Kvanner Aasvang
Collaborators: Rigshospitalet, Denmark, University Medical Center Groningen, Netherland, NOVA Medical School, Jagiellonian University, Bispebjerg Hospital
Conditions Patient Deterioration, Patient Monitoring, Clinical Deterioration
Enrollment 1,240 participants
Start Date 2026-03-16
Primary Completion 2027-12-01 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-05